---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-24-000028"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:56:44.152754+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q2 adj EPS $1.83 vs $2.21 YoY; cuts FY2024 adj EPS guidance to $6.40-$6.65

## Summary
- Total revenues $91.2B, up 2.6% YoY; GAAP diluted EPS $1.41 vs $1.48, Adjusted EPS $1.83 vs $2.21.
- Operating income $3.045B vs $3.234B; adjusted operating income $3.744B vs $4.481B, driven by Health Care Benefits segment pressure.
- FY2024 GAAP EPS guidance lowered to $4.95-$5.20 from at least $5.64; cash flow from ops guided to ~$9B from at least $10.5B.
- Health Care Benefits segment faces continued utilization pressure and unfavorable Medicare Advantage star ratings impact.
- CEO announces leadership changes in Health Care Benefits segment; strong performance in Health Services and Pharmacy & Consumer Wellness.

## SEC filing metadata
- accession: 0000064803-24-000028
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480324000028/0000064803-24-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480324000028/cvs-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-24-000028
- JSON: https://secwatch.observer/filing/0000064803-24-000028.json
- Plain text: https://secwatch.observer/filing/0000064803-24-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.